Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix

References

• Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10:S2.
   PubMed Web of Science ®Google Scholar
• Saling E. Prevention of prematurity – a complex undertaking reply. J Perinat Med. 2012;40:103.
   Web of Science ®Google Scholar
• Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;2:CD004352.
   PubMed Web of Science ®Google Scholar
• Flenady V, Wojcieszek AM, Papatsonis DNM, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;6:CD002255.
   PubMed Web of Science ®Google Scholar
• Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226
   PubMed Web of Science ®Google Scholar
• Gaunekar NN, Raman P, Bain E, et al. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;10:CD004071.
   Google Scholar
• Dodd JM, Crowther CA, Middleton P, Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev. 2012;12:CD003927.
   PubMedGoogle Scholar
• Romero R, Yeo L, Miranda J, et al. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med. 2014;41:27–44.
   Web of Science ®Google Scholar
• Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008;31:579–587.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Hassan SS, Romero R, Vidyadhari D, et al. PREGNANT trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18–31.
   PubMed Web of Science ®Google Scholar
• Myers KM, Fetlovich H, Mazza E, et al. The mechanical role of the cervix in pregnancy. J Biomech. 2015;48:1511–1523.
   PubMed Web of Science ®Google Scholar
• Myers K, Socrate S, Tzeranis D, et al. Changes in the biochemical constituents and morphologic appearance of the human cervical stroma during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2009;144:S82–S89.
   PubMed Web of Science ®Google Scholar
• Mahendroo M. Cervical remodeling in term and preterm birth: insights from an animal model. Reproduction. 2012;143:429–438.
   PubMed Web of Science ®Google Scholar
• Timmons BC, Reese J, Socrate S, et al. Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening. Endocrinology. 2014;155:287–298.
   PubMed Web of Science ®Google Scholar
• Zakar T, Mesiano S. How does progesterone relax the uterus in pregnancy? N Engl J Med. 2011;364:972–973.
   PubMed Web of Science ®Google Scholar
• Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol. 2012;357:108–118.
   PubMed Web of Science ®Google Scholar
• Check JH, Cohen R, DiAntonio A, et al. The demonstration that the immunomodulatory protein the progesterone induced blocking factor significantly rises in males with short term progesterone exposure provides new insights into the immunology of pregnancy. Fertil Steril. 2013;99:S22–S23.
   Web of Science ®Google Scholar
• Dodd JM, Jones L, Flenady V, et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013;7:CD004947.
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides KH, Conde-Agudelo A, et al. Vaginal progesterone decreases preterm birth ≤34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016;48:308–317.
   PubMed Web of Science ®Google Scholar
• Kuon RJ, Garfield RE. Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts Views Vis Obgyn. 2012;4:110–119.
   PubMedGoogle Scholar
• Baumbach J, Shi S, Shi L, et al. Inhibition of uterine contractility with various tocolytics with and without progesterone: in vitro studies. Am J Obstet Gynecol. 2012;206:254.e1–255.
   PubMed Web of Science ®Google Scholar
• Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labor: a randomized controlled trial. Aust N Z J Obstet Gynaecol. 2008;48:58–63.
   PubMed Web of Science ®Google Scholar
• Pustotina OA. Placental insufficiency and threatened preterm delivery are arguments for use of progesteron drugs. Rus Vest Akush Gynecol (Russian). 2006;2:51–54.
   Google Scholar
• Pessel C, Moni S, Zork N, et al. The effect of intramuscular progesterone on the rate of cervical shortening. Am J Obstet Gynecol. 2013;209:269.e1–267.
   Web of Science ®Google Scholar
• Ruddock NK, Shi S-Q, Jain S, et al. Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol. 2008;199:391.e1–391.e7.
   Web of Science ®Google Scholar
• Winer N, Bretelle F, Senat M-V, et al. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. Am J Obstet Gynecol. 2015;212:485.e1–410.
   Web of Science ®Google Scholar
• Romero R, Stanczyk FZ. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. Am J Obstet Gynecol. 2013;208:421–426.
   PubMed Web of Science ®Google Scholar
• Areeruk W, Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor. Sci Rep. 2016;6:20638.
   PubMed Web of Science ®Google Scholar
• Brocklehurst P, Gordon A, Heatley E, Milan SJ, Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;1:CD000262.
   PubMed Web of Science ®Google Scholar
• Romero R, Hassan SS, Gajer P, et al. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome. 2014;2:18.
   PubMed Web of Science ®Google Scholar
• Ghartey J, Bastek AJ, Brown AG, et al. Women with preterm birth have a distinct cervicovaginal metabolome. American J Obstet Gynecol. 2015;212:776.e1–776.e12.
   Google Scholar
• Srinivasan S, Morgan MT, Fiedler TL, et al. Metabolic signatures of bacterial vaginosis. MBio. 2015;6:e00204–e00215.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Nhan-Chang CL, Workowski K, et al. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011; 205:177–190.
   PubMed Web of Science ®Google Scholar
• Witkin SS, Mendes-Soares H, Linhares IM, et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: Implications for protection against upper genital tract infections. mBio 4:e00460-13. doi:10.1128/mBio.00460-13
   PubMed Web of Science ®Google Scholar
• Mirmonsef P, Zariffard MR, Gilbert D, et al. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol. 2012;67:391–400.
   PubMed Web of Science ®Google Scholar
• Cicinelli E, Borraccino V, Petruzzi D, et al. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil Steril. 1996; 65:860–862.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC. FIGO Committee report. Best practice in maternal–fetal medicine. Inter J Gynecol Obstet. 2015;128:80–82.
   PubMed Web of Science ®Google Scholar